Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Nicardipine for Vasospasm in Aneurysmal Subarachnoid Hemorrhage
NCT06329635Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- May 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicardipine in cerebral vasospasm (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Modified Rankin Scale at Day 365. Started May 2024; status: recruiting.
02
Drugs
nicardipine
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT06329635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06329635.